A survey by Veeva Systems ($VEEV) found biopharma companies still use paper or simple electronic systems to manage trial master files (TMFs). Paper and email are the primary means of sharing files with CROs, sites and regulators, despite the likes of Veeva talking up the benefits of using electronic TMF applications. Release